Cleveland BioLabs
CBLI
#9801
Rank
ยฃ36.83 M
Marketcap
ยฃ2.38
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Revenue for Cleveland BioLabs (CBLI)

Revenue in 2020 (TTM): ยฃ0.49 Million

According to Cleveland BioLabs 's latest financial reports the company's current revenue is ยฃ0.47 Million. In 2019 the company made a revenue of ยฃ0.83 Million a decrease over the revenue in the year 2018 that were of ยฃ0.85 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cleveland BioLabs from 2004 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)ยฃ0.49 M-41.14%
2019ยฃ0.83 M-2.18%
2018ยฃ0.85 M-41.58%
2017ยฃ1.46 M-44.62%
2016ยฃ2.64 M29.92%
2015ยฃ2.03 M-26.84%
2014ยฃ2.77 M-56.39%
2013ยฃ6.37 M137.71%
2012ยฃ2.68 M-59.38%
2011ยฃ6.59 M-42.67%
2010ยฃ11.5 M6.87%
2009ยฃ10.76 M204.87%
2008ยฃ3.53 M133.12%
2007ยฃ1.51 M18.17%
2006ยฃ1.28 M50%
2005ยฃ0.85 M78.97%
2004ยฃ0.47 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
ยฃ0.16 M-64.23%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.48 B 101,518.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ27.00 B 5,692,937.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ42.31 B 8,921,750.72%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
ยฃ36.05 B 7,602,117.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ35.67 B 7,521,571.71%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
ยฃ31.79 B 6,702,964.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ44.60 B 9,404,118.14%๐Ÿ‡บ๐Ÿ‡ธ USA